Since the carrier molecule of fatty acids, acyl-CoA, can not cross the cell membrane of the mitochondria, a deficiency of carnitine causes a reduction in the concentration of fatty acids in the mitochondria and, consequently, a reduced production of energy
it is associated with significant increase in the incidence of stroke, AF recurrence, and cardiovascular mortality
This provides a clear view into how these therapies are being integrated into diabetes care at scale and highlights the value of Marketplace data for tracking treatment adoption and patient outcomes in real time (Figure 1)
J Parent Enteral Nutr 1990
The update reads, Use of WEGOVY has been associated with gastrointestinal adverse reactions, sometimes severe
The uric acid is taken up by cells as a substrate for FAO